Page last updated: 2024-11-05

4-dimethylaminophenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Dimethylaminophenol, also known as p-Dimethylaminophenol, is an organic compound with the formula CH3)2NC6H4OH. It is a white to light brown solid that is soluble in water. 4-Dimethylaminophenol is a versatile chemical with a wide range of applications, including as a dye intermediate, antioxidant, and photographic developer. It is also used in the synthesis of pharmaceuticals and other fine chemicals. 4-Dimethylaminophenol is synthesized by the reaction of phenol with dimethylamine in the presence of a catalyst, such as zinc chloride or aluminum chloride. It is a strong reducing agent and can be oxidized to form a quinone. 4-Dimethylaminophenol is also a photosensitive compound and is used in photographic developers. It is known to be toxic and can cause skin and eye irritation. 4-Dimethylaminophenol is an important compound that is studied for its potential applications in various fields. It is a versatile chemical with a wide range of applications, and its synthesis, effects, and importance are of significant interest to researchers.'

4-dimethylaminophenol: in combination with SODIUM NITRITE antagonizes experimental cyanide poisoning; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID22174
CHEMBL ID3707216
CHEBI ID135941
SCHEMBL ID224308
MeSH IDM0073886

Synonyms (37)

Synonym
unii-x387l5559o
x387l5559o ,
619-60-3
4-(dimethylamino)phenol
phenol, 4-(dimethylamino)-
AE-562/43286954
n,n-dimethyl-4-aminophenol
p-(dimethylamino)phenol
einecs 210-604-8
phenol, p-(dimethylamino)-
dmap (antidote)
4-dimethylaminophenol
n,n-dimethyl-p-hydroxyaniline
p-hydroxy-n,n-dimethylaniline
CHEBI:135941
JVVRCYWZTJLJSG-UHFFFAOYSA-N
AKOS006220509
SCHEMBL224308
MB02001
para-dimethylaminophenol
4-(dimethylamino)phenol [who-dd]
p-dimethylaminophenol
CHEMBL3707216
mfcd01707548
DTXSID70210932
CS-W008911
Z137981254
DB13549
DS-15612
Q229950
4-(dimethylamino)phenol; 4-n,n-dimethylaminophenol; p-hydroxy-n,n-dimethylaniline
4-dimethyl amino phenol
4-dimethylamino-phenol
A868587
EN300-176799
HY-34154
PD071838

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The oral LD50 in female mice was 946 mg kg-1, in male rats, 780 mg kg-1, in female rats 689 mg kg-1 and in female guinea-pigs 1032 mg kg-1."( The acute intravenous and oral toxicity in mice, rats and guinea-pigs of 4-dimethylaminophenol (DMAP) and its effects on haematological variables.
Marrs, TC; Scawin, J; Swanston, DW, 1984
)
0.5
" The results indicate toxic effects in both treatment groups at a dose known to induce methaemoglobin concentration to the level of antidotal efficiency in cyanide intoxication."( Toxicity evaluation of two treatment regimens for cyanide poisoning.
Bhattacharya, R; Dube, SN; Kumar, D; Pant, SC,
)
0.13

Compound-Compound Interactions

ExcerptReferenceRelevance
"A sensitive and reproducible LC-ESI/MS/MS method, which was combined with the precolumn dansyl chloride derivatization to enhance the signal intensity of analytes, was developed to determine blood 4-dimethylaminophenol (DMAP) concentrations."( Determination of 4-dimethylaminophenol concentrations in dog blood using LC-ESI/MS/MS combined with precolumn derivatization.
Ruan, JX; Wang, XY; Yuan, M; Zhang, ZQ; Zhang, ZW; Zhuang, XM, 2008
)
0.87

Bioavailability

ExcerptReferenceRelevance
" In the normal unintoxicated animal an intramuscular injection of 20 mg kg-1 sodium nitrite will form 20% methemoglobin; however, in acute cyanide intoxication the associated severe bradycardia appears to limit the rate of absorption and thus the rapid formation of methemoglobin."( Effectiveness of intramuscularly administered cyanide antidotes on methemoglobin formation and survival.
Vick, JA; Von Bredow, JD,
)
0.13

Dosage Studied

ExcerptRelevanceReference
" Dosing with DMAP at the maximum tolerated dose produced Heinz body haemolytic anaemia in rats and Heinz bodies unaccompanied by anaemia in mice."( The acute intravenous and oral toxicity in mice, rats and guinea-pigs of 4-dimethylaminophenol (DMAP) and its effects on haematological variables.
Marrs, TC; Scawin, J; Swanston, DW, 1984
)
0.5
"Cyanide toxicity can be reduced by the use of methemoglobin (MetHb) formers, and antidotal dosage is based on the extent of MetHb formation."( Analysis of hemoglobin derivatives by capillary isoelectric focusing and its application in the antidotal research of cyanide poisoning.
Korte, WD; Shih, ML, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
dialkylarylamine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-199034 (72.34)18.7374
1990's11 (23.40)18.2507
2000's2 (4.26)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.17 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index4.01 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.64%)6.00%
Case Studies4 (7.27%)4.05%
Observational0 (0.00%)0.25%
Other49 (89.09%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]